MyAverix Finance
NS · Pharmaceuticals
Kopran Ltd (KOPRAN)
Pharmaceuticals & Biotechnology
Kopran Ltd (KOPRAN) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $9.52B, P/E ratio is 31.29, net margin is 9.8%, dividend yield is 1.52%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for KOPRAN
Kopran Ltd (KOPRAN) — FAQ
What is Kopran Ltd's market cap?
Kopran Ltd (KOPRAN) has a reported market cap of $9.52B (data as of 2026-07-10).
What is KOPRAN's P/E ratio?
The price-to-earnings (P/E) ratio for Kopran Ltd (KOPRAN) is 31.29 (data as of 2026-07-10).
Does Kopran Ltd pay a dividend?
Kopran Ltd (KOPRAN) shows a reported dividend yield of 1.52%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Kopran Ltd in?
Kopran Ltd (KOPRAN) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is KOPRAN listed on?
KOPRAN is listed on NS.
What is Kopran Ltd's net margin?
Kopran Ltd (KOPRAN) reports a net margin of 9.8% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.